References
Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983–988
Slot KB, Dorman P, Lewis S, Dennis M, Sandercock P (2008) Oxfordshire Community Stroke Project, the International Stroke Trial (UK); Lothian Stroke Register. Br Med J 7640:376–379
Dulli DA, Stanko H, Levine RL (2003) Atrial fibrillation is associated with severe acute ischemic stroke. Neuroepidemiology 22:118–123
Luengo-Fernandez R, Gray AM, Rothwell PM (2006) Population-based study of determinants of initial secondary care costs of acute stroke in the United Kingdom. Stroke 37:2579–2587
Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369–2429
Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, Murray E (2007) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370:493–503
Rash A, Downes T, Portner R, Yeo WW, Morgan N, Channer KS (2007) A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age Ageing 36:151–156
Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S (2007) Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 115:2689–2696
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Said, S.M., Braun-Dullaeus, R.C. Comment on the European guidelines for the management of atrial fibrillation. Clin Res Cardiol 100, 543–544 (2011). https://doi.org/10.1007/s00392-010-0280-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-010-0280-1